Hospira, Inc. Discontinues 5% Alcohol in 5% Dextrose Injection Drug Product

San Francisco, Calif. – Hospira announces it has made a business decision to discontinue manufacturing of 5% Alcohol in 5% Dextrose Injection drug product (NDC# 0409-1500-05).

To view a complete list of discontinued drugs from the FDA, visit: http://www.fda.gov/cder/drug/shortages/default.htm#disc

Contact Suvarna Bhatt at sbhatt@biospace.com.